The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...

GSK (LON:GSK) has raised its long-term revenue outlook, now expecting sales to exceed 40 billion by 2031, up from 38 billion.

GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around ...

Strong full-year trading and an improving outlook have propelled GSK's share price higher, as Royston Wild explains. The post ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

Personalized bioengineered implant scaffolds offer customizable medical solutions for tissue and organ regeneration. This Review provides a framework for navigating the regulatory process and ...

GSK and the University of Oxford have entered a new research ... which includes the Institute of Molecular and Computational Medicine established in 2021. The Institute has made strides in the ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target ...

In 2021, GSK and Oxford established the Institute of Molecular and Computational Medicine to drive forward the research and development of new medicines.

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I’ve investigated whether this is the case. When investing, your capital is ...

If your symptoms are serious or your doctor thinks something else is causing them, they might recommend a prescription medicine. Most people don't need any kind of treatment for mild cold symptoms.